Qardio, Inc.
COVINA, CA · Founded 2012 · CIK 0001560938 · Medtech · Private
Mobile health monitoring devices and software platform for tracking blood pressure, ECG, heart rate, weight, and body composition
qardio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $39M
- 9 Form D · Jul 2020
- 75 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 21
- 6 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20122014201620182020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $325,000 | |
| Private capital raised | Form D · SEC | $600,000 | |
| Private capital raised | Form D · SEC | $948,000 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $10,000,000 | |
| Private capital raised | Form D · SEC | $20,000,000 | |
| Private capital raised | Form D · SEC | $22,239,400 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $10,142,109 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $5,013,526 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 922 | BIODTECH, INC. | — | $575K |
| 923 | Innova Vascular, Inc. | — | $22M |
| 924 | AGITATED SOLUTIONS, LLC | — | $515K |
| 925 | Qardio, Inc. | — | $39M |
| 926 | ASC JV LLC | — | $750K |
| 927 | Alexza Pharmaceuticals Inc. | — | $37M |
| 928 | APO Technologies, Inc | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Mike AlvarezDirector · Executive Officer
- Alex BezuglyDirector
- Alexander BezuglyExecutive Officer
- Willard GardinerDirector
- Rosario IannellaDirector · Executive Officer
- Jorrit KeldermanExecutive Officer
- Marco PelusoDirector · Executive Officer
- Mark PrinceDirector · Executive Officer
- Greg RichDirector · Executive Officer
- Dev SinghExecutive Officer
- David SteinhausDirector
- Luca TassanDirector
- Lucas TassanDirector
- Bram van den HeuvelExecutive Officer
- Leopoldo ZambelettiDirector
- Alexis ZervoglosExecutive Officer
- Carlo ZuccaroDirector
Patents
- Blood Pressure Measurement Device With Removable Cuff And Methods Thereforapplication
- Systems And Methods For Contextualized Recording Of Biometric Measurementsgranted
- Methods For Authenticating Device-to-device Communicationgranted
- Devices, Systems And Methods For Segmented Device Behaviorgranted
- Devices, Systems And Methods For Contextualized Recording Of Biometric Measurementsapplication
- Scalegranted
- Ekg Monitorgranted
- Methods And Systems For Acquiring Diagnostic Informationapplication
- Devices And Methods For Measuring Blood Pressureapplication
- Blood Pressure Monitorgranted
- Methods For Authenticating Device To Device Communicationapplication
- Methods And Systems For Acquiring Diagnostic Informationapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.